See how scientific and medical advances have propelled newborn screening forward.
We are heading up a newborn sequencing consortium that will revolutionize and shorten the diagnostic journey.
We are transforming pediatric healthcare through the power of Rapid Precision Medicine™
We’re setting a new standard of care for newborns and children with rare undiagnosed diseases.
Join our dynamic team of professionals from around the world
GENOMEWEB:In a paper published this week in the American Journal of Human Genetics, collaborators led by the Rady Children’s Institute for Genomic Medicine (RCIGM) formally spelled out plans to improve detection and treatment of rare hereditary pediatric diseases through rapid whole-genome sequencing (rWGS).
Study demonstrates feasibility of NBS-rWGS prototype to rapidly screen for several hundred genetic diseases with effective interventions
GTRx, a clinical decision support tool, can provide front-line clinicians with the information they need to initiate precision treatments for critically ill infants and …
Wednesday September 07, 2022 |
Monday October 17, 2022 | 6pm PT
Chief Strategy & Innovation Officer Wendy Benson joins a panel discussing "The Next Frontier of Genetics & Privacy: NBS at the Intersection."
The lead author from a recent meta-analysis on reanalysis of next-generation sequencing will share the process for developing this review and discuss recommendations for future standards in reanalysis. Featuring Dr. Pei Dai, and RCIGM's Katarzyna Ellsworth, PhD FACMG CGMB.
*Free Registration is required
Wednesday October 05, 2022 | thru October 6, 2022
*Free Registration is required
Rapid Precision Medicine™ is here now. We are setting the standard for pediatric critical care by breaking barriers to expand access to genomically-informed, personalized care nationwide. We offer many opportunities to collaborate with as we work to save and improve lives.
© 2022 Rady Children's Institute for Genomic Medicine.
